Xenetic Biosciences Inc. (NASDAQ: XBIO) Stock Information | RedChip

Xenetic Biosciences Inc. (NASDAQ: XBIO) Listen to this Section


$3.02
-0.2700 ( -8.21% ) 60.0K

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

Market Data


Open


$3.02

Previous close


$3.29

Volume


60.0K

Market cap


$4.85M

Day range


$2.87 - $3.30

52 week range


$2.78 - $5.97

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 14, 2024
10-q Quarterly Reports 49 Aug 13, 2024
8-k 8K-related 14 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 16 May 22, 2024
8-k 8K-related 17 May 10, 2024
10-q Quarterly Reports 45 May 09, 2024
10-k/a Quarterly Reports 3 Apr 26, 2024
8-k 8K-related 16 Mar 22, 2024
10-k Annual reports 75 Mar 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.